CAOPLUS
CAOPLUS, licence 80083143: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Liquid Calcium Softgel, US Pharm Caoplus
- Licence holder
- Vita Naturals Inc.
- NPN or DIN-HM
- 80083143
- Status
- Active licence
- Licence date
- 14 February 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Carbonate de calcium | 300.0 mg | 600,000 µg |
| Vitamine D Source : Cholécalciférol | 2.5 microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 100.0 UI | 5 µg |
Non-medicinal ingredients
Lécithine, Eau purifiée, Dioxyde de titane, Huile de fève de soja, Gélatine, Glycérine, Cire d'abeille jaune
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis / may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones. Helps in the development and maintenance of bones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80083143
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.